Verenium to Announce Third Quarter 2009 Financial Results

CAMBRIDGE, Mass., Nov. 2 /PRNewswire-FirstCall/ -- Verenium Corporation
(Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic
ethanol and high-performance specialty enzymes, announced today that it will
release third quarter 2009 financial results on Monday, November 9, 2009 at
8:00 a.m. ET. In conjunction with the release, the Company will host a
conference call with live webcast on Monday, November 9 at 10:00 a.m. ET.

The call may be accessed by dialing 888-661-5167 (domestic) or 913-312-0386
(international) five minutes prior to start time and providing the passcode
7441265. A link to the live webcast may be accessed by visiting the
"Investors" section of the Company's website at http://www.verenium.com. A
replay of the event will be available on the Company's website approximately
two hours after the call and will be archived for 30 days.

About Verenium
Verenium Corporation is a leader in the development and commercialization of
cellulosic ethanol, an environmentally-friendly and renewable transportation
fuel, as well as high-performance specialty enzymes for applications within
the biofuels, industrial, and animal health markets. The Company possesses
integrated, end-to-end capabilities and cutting-edge technology in
pre-treatment, novel enzyme development, fermentation and project development
for next-generation biofuels. Through Vercipia, a 50-50 joint venture with BP,
the Company is moving rapidly to commercialize cellulosic technology for the
production of ethanol from a wide array of non-food feedstocks, including
dedicated energy crops, agricultural waste, and wood products. In addition to
the vast potential for biofuels, a multitude of large-scale industrial
opportunities exist for the Company for products derived from the production
of low-cost, biomass-derived sugars.

Verenium's Specialty Enzyme business harnesses the power of enzymes to create
a broad range of specialty products to meet high-value commercial needs.
Verenium's world class R&D organization is renowned for its capabilities in
the rapid screening, identification, and expression of enzymes-proteins that
act as the catalysts of biochemical reactions. For more information on
Verenium, visit http://www.verenium.com.

Forward Looking Statements
Statements in this press release that are not strictly historical are
"forward-looking" and involve a high degree of risk and uncertainty. These
include, but are not limited to, statements related to the Company's
operations, capabilities, commercialization activities, target markets,
cellulosic ethanol facilities, target markets and future financial
performance, results and objectives, all of which are prospective. Such
statements are only predictions, and actual events or results may differ
materially from those projected in such forward-looking statements. Factors
that could cause or contribute to the differences include, but are not limited
to, risks associated with Verenium's technologies, risks associated with the
costs, labor requirements and labor availability associated with Verenium's
demonstration plant, risks associated with Verenium's ability to obtain
additional capital to support its planned operations and financial
obligations, risks associated with Verenium's dependence on patents and
proprietary rights, risks associated with Verenium's protection and
enforcement of its patents and proprietary rights, technological, regulatory,
competitive and other risks related to development, production, and
commercialization of cellulosic ethanol and other biofuels and the commercial
prospects of those industries, Verenium's dependence on existing
collaboration, manufacturing, and/or license agreements, and its ability to
achieve milestones under existing and future collaboration agreements, the
ability of Verenium and its partners to commercialize its technologies and
products (including by obtaining any required regulatory approvals) using
Verenium's technologies and timing for launching any commercial products and
projects, the ability of Verenium and its collaborators to market and sell any
products that it or they commercialize, the development or availability of
competitive products or technologies, the future ability of Verenium to enter
into and/or maintain collaboration and joint venture agreements and licenses,
changes in the U.S. or global energy markets and laws and regulations
applicable to them, and risks and other uncertainties more fully described in
the Company's filings with the Securities and Exchange Commission, including,
but not limited to, the Company's annual report on Form 10-K for the year
ended December 31, 2008 and any updates contained in its subsequently filed
quarterly reports on Form 10-Q. These forward-looking statements speak only
as of the date hereof, and the Company expressly disclaims any intent or
obligation to update these forward-looking statements.

Contact:
Verenium Corporation
Sarah Carmody
Sr. Corporate Communications Associate
617-674-5357
sarah.carmody@verenium.com

SOURCE Verenium Corporation

Sarah Carmody, Sr. Corporate Communications Associate of Verenium Corporation,
+-1-617-674-5357, sarah.carmody@verenium.com